We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.7B
AUM Growth
+$362M
Cap. Flow
-$223M
Cap. Flow %
-1.19%
Top 10 Hldgs %
44.6%
Holding
254
New
8
Increased
16
Reduced
110
Closed
10

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$69.2M
2
UNH icon
UnitedHealth
UNH
+$23.6M
3
UNP icon
Union Pacific
UNP
+$22.1M
4
RH icon
RH
RH
+$7.93M
5
EPD icon
Enterprise Products Partners
EPD
+$7.27M

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$58.2M
2
AAPL icon
Apple
AAPL
+$20.5M
3
PM icon
Philip Morris
PM
+$20.4M
4
ORCL icon
Oracle
ORCL
+$16.3M
5
KO icon
Coca-Cola
KO
+$14.3M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.82%
2 Financials 16.56%
3 Energy 15.53%
4 Technology 10.03%
5 Healthcare 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMG icon
226
Affiliated Managers Group
AMG
$9.51B
$232K ﹤0.01%
1,400
AEP icon
227
American Electric Power
AEP
$70.4B
$231K ﹤0.01%
3,318
IJK icon
228
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.6B
$230K ﹤0.01%
4,680
SRCL
229
DELISTED
Stericycle Inc
SRCL
$229K ﹤0.01%
3,000
ETN icon
230
Eaton
ETN
$141B
$218K ﹤0.01%
2,803
YUMC icon
231
Yum China
YUMC
$15.7B
$218K ﹤0.01%
+5,540
New +$200K
HHH icon
232
Howard Hughes
HHH
$3.94B
$214K ﹤0.01%
1,827
PR
233
Permian Resources
PR
$17.4B
$211K ﹤0.01%
13,350
D icon
234
Dominion Energy
D
$62B
$210K ﹤0.01%
2,741
OMC icon
235
Omnicom Group
OMC
$23.5B
$207K ﹤0.01%
2,492
-1,038
-29% -$86.6K
BRKR icon
236
Bruker
BRKR
$9.4B
$204K ﹤0.01%
+7,060
New +$182K
CSL icon
237
Carlisle Companies
CSL
$13.5B
$204K ﹤0.01%
2,135
TEVA icon
238
Teva Pharmaceuticals
TEVA
$40.4B
$204K ﹤0.01%
+6,150
New +$190K
MPLX icon
239
MPLX
MPLX
$58.6B
$200K ﹤0.01%
5,995
AGN
240
DELISTED
Allergan plc
AGN
$200K ﹤0.01%
+824
New +$194K
F icon
241
Ford
F
$60.9B
$159K ﹤0.01%
14,199
ROX
242
DELISTED
Castle Brands, Inc.
ROX
$91K ﹤0.01%
52,830
NNVC icon
243
NanoViricides
NNVC
$39.3M
$39K ﹤0.01%
1,429
WTI icon
244
W&T Offshore
WTI
$525M
$23K ﹤0.01%
11,858
CVS icon
245
CVS Health
CVS
$135B
-3,893
Closed -$306K
TRGP icon
246
Targa Resources
TRGP
$56.8B
-3,410
Closed -$204K
ALXN
247
DELISTED
Alexion Pharmaceuticals
ALXN
-3,075
Closed -$373K
GRUB
248
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
-149,066
Closed -$9.81M
APC
249
DELISTED
Anadarko Petroleum
APC
-3,801
Closed -$236K
ESRX
250
DELISTED
Express Scripts Holding Company
ESRX
-25,325
Closed -$1.67M

Similar funds

Fayez Sarofim & Co's Q2 2017 Portfolio in Review

As of Q2 2017, Fayez Sarofim & Co held 254 positions worth $18.7B, up 2% from $18.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Fayez Sarofim & Co's Q2 2017 filing shows 8 new, 16 increased, 110 reduced and 10 closed positions. Its largest new stake was RH: 150,000 shares worth $9.68M. The largest sale was Target, an estimated $58.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 32% a quarter earlier, followed by Financials and Energy.

  • Fayez Sarofim & Co's largest Q2 2017 buy was RH: 150,000 shares worth $9.68M.
  • Fayez Sarofim & Co added most to Microsoft in Q2 2017, an estimated $69.2M increase.
  • Fayez Sarofim & Co's biggest Q2 2017 reduction was Target, cutting an estimated $58.2M.
  • Fayez Sarofim & Co fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2017, selling an estimated $9.81M.
  • Fayez Sarofim & Co's ten largest holdings make up 45% of its $18.7B portfolio in Q2 2017.
  • Fayez Sarofim & Co opened 8 new positions and closed 10 in Q2 2017.
  • Fayez Sarofim & Co's portfolio value rose 2% quarter-over-quarter to $18.7B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2017, filed 11 Aug 2017.